Dr. Reddy's Laboratories Limited (NYSE:RDY) announces that the company's annual report on Form 20-F for the year ended March 31, 2008 is available on its website --
http://www.drreddys.com/investors/pdf/Fiscal2008Form20F.pdf and can be accessed by selecting 'SEC Filings' under the 'Investors' menu. ADS holders also have the ability to receive a hard copy of the company's complete audited financial statements free of charge upon request.
About Dr. Reddy's
Dr. Reddy's Laboratories (NYSE:RDY) is a global, vertically integrated pharmaceutical company with a presence across the value chain, producing and delivering safe, innovative, and high quality finished dosage forms, active pharmaceutical ingredients and biotechnology products, which are marketed to over 100 countries including US, Europe, Russia, India and China.
The Company conducts NCE drug discovery research in the areas of diabetes, cardiovascular, anti-infectives, inflammation and cancer. Its drug discovery effort is carried out at its research facilities in Atlanta, USA, and in Hyderabad, India. For more details visit www.drreddys.com.
Disclaimer
This press release includes forward-looking statements, as defined in the U.S. Private Securities Litigation Reform Act of 1995. We have based these forward-looking statements on our current expectations and projections about future events. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results to differ materially. Such factors include, but are not limited to, changes in local and global economic conditions, our ability to successfully implement our strategy, the market acceptance of and demand for our products, our growth and expansion, technological change and our exposure to market risks. By their nature, these expectations and projections are only estimates and could be materially different from actual results in the future.
